Get started
Author

Normi D. Gajjar

Observed name: Normi Gajjar
Observed institution: Gujarat Technological University
ORCID: 0000-0002-9019-7753
Observed ORCID: 0000-0002-9019-7753
OpenAlex ID: A5041626866
In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis
2021 · Normi D. Gajjar, Tejas M. Dhameliya, et al. · Journal of Molecular Structure · 87
PDF
In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis
2021 · Prinsa R. Nagar, Normi D. Gajjar, et al. · Journal of Molecular Structure · 61
PDF
Recent advancements in applications of ionic liquids in synthetic construction of heterocyclic scaffolds: A spotlight
2021 · Tejas M. Dhameliya, Prinsa R. Nagar, et al. · Journal of Molecular Liquids · 58
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
2022 · Zoufang Huang, Vivek P. Chavda, et al. · Frontiers in Pharmacology · 51
PDF
Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions
2021 · Tejas M. Dhameliya, Kaushikkumar A. Bhakhar, et al. · Journal of Molecular Structure · 44
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
2021 · Vivek P. Chavda, Normi Gajjar, et al. · European Journal of Medicinal Chemistry Reports · 40
PDF
Identification of anti-mycobacterial agents against mmpL3: Virtual screening, ADMET analysis and MD simulations
2021 · Kaushikkumar A. Bhakhar, Normi D. Gajjar, et al. · Journal of Molecular Structure · 40
Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
2022 · Tejas M. Dhameliya, Prinsa R. Nagar, et al. · Molecular Diversity · 30
PDF
In silico screening, ADMET analysis and MD simulations of phytochemicals of Onosma bracteata Wall. as SARS CoV-2 inhibitors
2023 · Udaykumar G. Vegad, Normi D. Gajjar, et al. · 3 Biotech · 18
PDF
In‐silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV‐2
2022 · Dipen K. Sureja, Ashish P. Shah, et al. · ChemistrySelect · 17
Indole‐2‐carboxamides as New Anti‐Mycobacterial Agents: Design, Synthesis, Biological Evaluation and Molecular Modeling against mmpL3
2022 · Kaushikkumar A. Bhakhar, Punit V. Vaghela, et al. · ChemistrySelect · 17
Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant
2023 · Meha P. Mehta, Normi D. Gajjar, et al. · Indian Journal of Pharmacology · 7
PDF
From Structure to Activity: Exploration of QSAR Modelling to Predict Antibacterial Activity Against Pseudomonas aeruginosa
2025 · Normi D. Gajjar, Kaushik A. Joshi, et al. · ChemistrySelect · 3
Evaluating the anti-bacterial activities of potentized medicines on the clinical isolates from the urine samples
2024 · Normi Gajjar, Gitanjali Talele, et al. · Indian Journal of Pharmacology · 1
Network pharmacology, molecular docking, and preliminary in vitro evaluation of Ponatinib in cardiac hypertrophy
2026 · Anil Kumar Prajapati, Gaurang Shah, et al. · Discover Pharmaceutical Sciences
PDF
Exploring the Mechanisms of Phytoconstituents in Polycystic Ovary Syndrome through Network Pharmacology
2026 · Nisha H. Khobragade, Devang B. Sheth, et al. · Asian Journal of Pharmaceutical Research
Network Pharmacology Based Insights into Gut Microbial Metabolites as Modulators of Type 1 and Type 2 Inflammation in Bronchial Asthma
2026 · Normi Gajjar, Gaurang Shah, et al. · Journal of Pharmaceutical Innovation
Works count: 17
Citation count: 474
H-index: 11
I10-index: 11
Year
Topic
Type